Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Cell Line Development
Sort By
Newest First
Sign in
1 / 1
1 / 1
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
Jiyeon Lee; Hyelyoung Jang
Samsung Biologics
POD-01-24-CL-01
Jan 16, 2024
CMC
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
Jesse McCool, Ph.D.; David Schmidt, M.B.A., M.Sc.; Oren Beske, Ph.D.; Stephen Monks, Ph.D.
Wheeler Bio
PAO-07-23-CL-05
Jul 26, 2023
Cell Line Development Technology
Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering
Wheeler Bio
PR-M11-22-09
Nov 30, 2022
Cell Line Development
Integrating Cell Line and CMC Development
Stephen Hamilton, Ph.D.; Mike Brem
Wheeler Bio
PAO-06-022-CL-12
Sep 02, 2022
Cell Line Development
Wheeler Bio Integrates the Solentim® Ecosystem by Advanced Instruments to Deliver the Highest Level of Consistency Across Their Cell Line Development Workflow
Advanced Instruments
PR-M06-22-04
Jun 14, 2022
Capacity Expansion
German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand
Richter-Helm BioLogics
PR-M05-21-008
May 12, 2021
Cell Line Development
Rising Demand for Novel Cancer Treatment Approaches to Propel Cell Line Development Market through 2024
Global Market Insights
PAO-M11-19-NI-007
Nov 20, 2019
Strategic Collaboration
Berkeley Lights and TPG Biologics Enter into a Strategic Collaboration for Cell Line Development
Berkeley Lights
PR-M05-18-NI-099
May 25, 2018
